Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,011 | -$6,054 | -$6,433 | -$6,259 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $458 | $395 | $919 | $554 |
| Change in WC | -$2,065 | $657 | -$2,619 | -$3,406 |
| Other Non-Cash | $28 | -$11 | -$61 | $11 |
| Operating Cash Flow | -$5,589 | -$5,013 | -$8,194 | -$9,100 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$113 | -$111 | -$234 | $375 |
| Stock Issued | $8,522 | $10,198 | $241 | $16,643 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $8,409 | $10,087 | $7 | $17,018 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,820 | $5,074 | -$8,187 | $7,918 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,364 | $5,289 | $13,476 | $5,559 |
| End Cash | $13,183 | $10,364 | $5,289 | $13,476 |
| Free Cash Flow | -$5,589 | -$5,013 | -$8,194 | -$9,100 |